{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:24:04Z","timestamp":1787095444299,"version":"build-2736575974"},"reference-count":84,"publisher":"Georg Thieme Verlag KG","issue":"06","funder":[{"name":"Italian Ministry of Health, Bando Ricerca Corrente"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dysfunctional or quantitatively deficient von Willebrand factor (VWF) underlies von Willebrand disease (VWD), the most common inherited bleeding disorder. Type 2A VWD is a qualitative defect marked by impaired VWF-dependent platelet adhesion, typically reflected in disproportionately reduced ratios of platelet-dependent VWF activity to antigen (VWF activity\/VWF:Ag) and collagen binding to antigen (VWF:CB\/VWF:Ag). This phenotype results from a selective reduction or lack of high- and intermediate-molecular-weight multimers, which are essential for effective hemostasis under high shear stress. The lack of multimer arises from impaired multimer assembly and\/or increased proteolytic cleavage of VWF by ADAMTS13. Clinically, type 2A tends to present with greater severity than other type 2 variants, manifesting as mucocutaneous bleeding, often including heavy menstrual bleeding, epistaxis, post-surgical bleeding and gastrointestinal hemorrhage from angiodysplasia. Diagnosis relies on functional assays and VWF multimer analysis, supported by genetic testing that identifies subtype-specific mutations affecting VWF multimeric structure and therefore its function. Type 2A is typically inherited in an autosomal dominant manner, with rare exceptions of autosomal recessive inheritance. Structural and molecular studies are continuing to elucidate how domain-specific variants disrupt multimeric structure and thus interactions with its ligands. Management is guided by bleeding severity and includes desmopressin (following responsiveness testing) and VWF replacement therapy. This review provides an in-depth update on type 2A VWD, covering its epidemiology, pathophysiology across distinct subtypes, clinical manifestations, diagnostic approach, molecular and structural insights, and current therapeutic strategies.<\/jats:p>","DOI":"10.1055\/a-2778-9989","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T23:55:51Z","timestamp":1766793351000},"page":"618-627","source":"Crossref","is-referenced-by-count":1,"title":["Von Willebrand Disease Type 2A: An Update"],"prefix":"10.1055","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-7879","authenticated-orcid":false,"given":"Omid","family":"Seidizadeh","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-6005","authenticated-orcid":false,"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1915-3897","authenticated-orcid":false,"given":"Pier Mannuccio","family":"Mannucci","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1538-7836.2011.04320.x","article-title":"Biology and physics of von Willebrand factor concatamers","volume":"9","author":"T A Springer","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref2","first-page":"576","article-title":"Structure and function of von Willebrand factor","volume":"82","author":"Z M Ruggeri","year":"1999","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"O Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Y F Zhou","year":"2012","journal-title":"Blood"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"P J Lenting","year":"2015","journal-title":"Blood"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(88)90511-9","article-title":"The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers","volume":"52","author":"R J Wise","year":"1988","journal-title":"Cell"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF","volume":"100","author":"J B Rosenberg","year":"2002","journal-title":"Blood"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"A Petri","year":"2019","journal-title":"Nat Commun"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"F Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"M Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"O Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"A Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0031-1281032","article-title":"Diagnosis and management of von Willebrand disease in The Netherlands","volume":"37","author":"E M de Wee","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/a-2616-5161","article-title":"Landscape and spectrum of VWF variants in type 2 von Willebrand disease: insights from a German patient cohort","author":"H Yadegari","year":"2025","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"N Borr\u00e0s","year":"2017","journal-title":"Haematologica"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jth.15129","article-title":"Laboratory variability in the diagnosis of type 2 VWD variants","volume":"19","author":"S DiGiandomenico","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases","volume":"8","author":"O Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"U Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-0042-1757183","article-title":"Von Willebrand factor multimer analysis and classification: a comprehensive review and updates","volume":"49","author":"A Saadalla","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"P D James","year":"2021","journal-title":"Blood Adv"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)","volume":"77","author":"T S Zimmerman","year":"1986","journal-title":"J Clin Invest"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor","volume":"87","author":"J A Dent","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"W A Hassenpflug","year":"2006","journal-title":"Blood"},{"issue":"07","key":"ref26","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"S E Lyons","year":"1992","journal-title":"J Biol Chem"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"J J Sutherland","year":"2004","journal-title":"J Mol Model"},{"issue":"19","key":"ref28","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"P M Jacobi","year":"2012","journal-title":"Blood"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"R Schneppenheim","year":"2010","journal-title":"Blood"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/jth.12280","article-title":"A synonymous (c.3390C>T) or a splice-site (c.3380-2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A\/IIE)","volume":"11","author":"M T Pagliari","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"C Gaucher","year":"1994","journal-title":"Blood"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00209487","article-title":"Identification of a candidate missense mutation in a family with von Willebrand disease type IIC","volume":"95","author":"R Schneppenheim","year":"1995","journal-title":"Hum Genet"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI110700","article-title":"Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)","volume":"70","author":"Z M Ruggeri","year":"1982","journal-title":"J Clin Invest"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1111\/hae.12161","article-title":"Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient","volume":"19","author":"M S Enayat","year":"2013","journal-title":"Haemophilia"},{"issue":"01","key":"ref35","first-page":"96","article-title":"von Willebrand disease type 2A phenotypes IIC, IID and IIE: a day in the life of shear-stressed mutant von Willebrand factor","volume":"112","author":"M A Brehm","year":"2014","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease","volume":"93","author":"R Schneppenheim","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID)","volume":"63","author":"S Kinoshita","year":"1984","journal-title":"Blood"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1160\/TH06-08-0460","article-title":"Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease","volume":"96","author":"P Tjernberg","year":"2006","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V98.3.674","article-title":"Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease","volume":"98","author":"M S Enayat","year":"2001","journal-title":"Blood"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"P Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"14","key":"ref41","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jmb.2017.05.013","article-title":"Enhanced local disorder in a clinically elusive von Willebrand factor provokes high-affinity platelet clumping","volume":"429","author":"A Tischer","year":"2017","journal-title":"J Mol Biol"},{"issue":"19","key":"ref42","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Y V Sanders","year":"2015","journal-title":"Blood"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","volume":"21","author":"O Seidizadeh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref44","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.92.7.2428","article-title":"Platelet von Willebrand factor in inherited and acquired bleeding disorders","volume":"92","author":"P M Mannucci","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"103233","DOI":"10.1016\/j.rpth.2025.103233","article-title":"Deep molecular modeling and mechanistic insights into type 2A VWD with VWF A2 domain mutations","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"08","key":"ref46","doi-asserted-by":"crossref","first-page":"e0161310","DOI":"10.1371\/journal.pone.0161310","article-title":"Diagnostic value of measuring platelet von Willebrand factor in von Willebrand disease","volume":"11","author":"A Casonato","year":"2016","journal-title":"PLoS One"},{"issue":"09","key":"ref47","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1074\/jbc.M112.422618","article-title":"Mechanisms by which von Willebrand disease mutations destabilize the A2 domain","volume":"288","author":"A J Xu","year":"2013","journal-title":"J Biol Chem"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"e45207","DOI":"10.1371\/journal.pone.0045207","article-title":"Structural basis of type 2A von Willebrand disease investigated by molecular dynamics simulations and experiments","volume":"7","author":"G Interlandi","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"e0188405","DOI":"10.1371\/journal.pone.0188405","article-title":"A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct","volume":"12","author":"C J Lynch","year":"2017","journal-title":"PLoS One"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Q Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"J T Crawley","year":"2011","journal-title":"Blood"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood-2009-03-210369","article-title":"Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13","volume":"115","author":"T Wu","year":"2010","journal-title":"Blood"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1038\/s41598-018-24212-6","article-title":"Prediction of spacer-\u03b16 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces","volume":"8","author":"X Fang","year":"2018","journal-title":"Sci Rep"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"G Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref55","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1055\/s-0041-1726097","article-title":"Type 2A and 2M von Willebrand disease: differences in phenotypic parameters according to the affected domain by disease-causing variants and assessment of pathophysiological mechanisms","volume":"47","author":"A I Woods","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease","volume":"108","author":"E M de Wee","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288342","article-title":"Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype","author":"O Seidizadeh","year":"2025","journal-title":"Haematologica"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.2019003702","article-title":"How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease","volume":"136","author":"E Biguzzi","year":"2020","journal-title":"Blood"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/hematology.2022000390","article-title":"Special considerations in GI bleeding in VWD patients","volume":"2022","author":"N LJ Chornenki","year":"2022","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"03","key":"ref60","first-page":"588","article-title":"von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy","volume":"110","author":"C Crossette-Thambiah","year":"2025","journal-title":"Haematologica"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2009.03457.x","article-title":"Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization","volume":"7","author":"L Baronciani","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref62","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"I Bod\u00f3","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref63","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jtha.2024.05.006","article-title":"Application of genetic testing for the diagnosis of von Willebrand disease","volume":"22","author":"O Seidizadeh","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2017.09.025","article-title":"Von Willebrand disease mutation spectrum and associated mutation mechanisms","volume":"159","author":"A de Jong","year":"2017","journal-title":"Thromb Res"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"A C Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2016.08.009","article-title":"Mutations in the D'D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWF","volume":"145","author":"T C White-Adams","year":"2016","journal-title":"Thromb Res"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"102686","DOI":"10.1016\/j.rpth.2025.102686","article-title":"Challenges and considerations of genetic testing in von Willebrand disease","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","article-title":"Genetic testing for von Willebrand disease: the case against","volume":"8","author":"E J Favaloro","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and type 2A von Willebrand disease: similar but different","volume":"42","author":"E J Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref70","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1182\/bloodadvances.2024012626","article-title":"Type 2M\/2A von Willebrand disease: a shared phenotype between type 2M and 2A","volume":"8","author":"O Seidizadeh","year":"2024","journal-title":"Blood Adv"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease\u2014more often misidentified than correctly identified","volume":"22","author":"E J Favaloro","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hae.14204","article-title":"How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types","volume":"27","author":"E J Favaloro","year":"2021","journal-title":"Haemophilia"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"N T Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"07","key":"ref74","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"P M Mannucci","year":"2004","journal-title":"N Engl J Med"},{"issue":"16","key":"ref75","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood.2024026804","article-title":"DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis","volume":"145","author":"S Laan","year":"2025","journal-title":"Blood"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"A B Federici","year":"2004","journal-title":"Blood"},{"issue":"18","key":"ref77","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1182\/bloodadvances.2021006757","article-title":"Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease","volume":"6","author":"F Atiq","year":"2022","journal-title":"Blood Adv"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.15155","article-title":"Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy","volume":"19","author":"A Rauch","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/hae.15034","article-title":"Retrospective chart review of GI bleeding in people with von Willebrand disease","volume":"30","author":"J C Roberts","year":"2024","journal-title":"Haemophilia"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/MBC.0000000000000632","article-title":"Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report","volume":"28","author":"R Brown","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"17","key":"ref81","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"J C Gill","year":"2015","journal-title":"Blood"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/20406207211064064","article-title":"Prophylactic management of patients with von Willebrand disease","volume":"12","author":"M Franchini","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"04","key":"ref83","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.27602","article-title":"2025 clinical trials update on hemophilia, VWD, and rare inherited bleeding disorders","volume":"100","author":"D Jiang","year":"2025","journal-title":"Am J Hematol"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1055\/s-0040-1715442","article-title":"Ex vivo improvement of a von Willebrand disease type 2A phenotype using an allele-specific small-interfering RNA","volume":"120","author":"A de Jong","year":"2020","journal-title":"Thromb Haemost"},{"issue":"S 04","key":"ref85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hae.14518","article-title":"Towards novel treatment options in von Willebrand disease","volume":"28","author":"P J Lenting","year":"2022","journal-title":"Haemophilia"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2778-9989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:30:42Z","timestamp":1787092242000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2778-9989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":84,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2778-9989","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,26]]},"published":{"date-parts":[[2025,12,26]]}}}